STAAR Surgical Appoints New CFO, Elects Directors
Ticker: STAA · Form: 8-K · Filed: Mar 12, 2024 · CIK: 718937
| Field | Detail |
|---|---|
| Company | Staar Surgical Co (STAA) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, cfo, corporate-governance
TL;DR
STAAR Surgical names Patrick Williams as new CFO, effective March 11th. Board elections also confirmed.
AI Summary
STAAR Surgical Company announced on March 10, 2024, the appointment of Patrick Williams as Chief Financial Officer, effective March 11, 2024. Williams previously served as Interim CFO and brings extensive financial leadership experience to the role. The company also reported on director elections and compensatory arrangements.
Why It Matters
The appointment of a permanent CFO is a significant leadership change that can impact financial strategy and investor confidence. Director elections are crucial for corporate governance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance matters like executive appointments and director elections, with no immediate financial distress or major operational changes indicated.
Key Players & Entities
- STAAR Surgical Company (company) — Registrant
- Patrick Williams (person) — Appointed Chief Financial Officer
- March 10, 2024 (date) — Date of report
- March 11, 2024 (date) — Effective date for CFO appointment
- Delaware (jurisdiction) — State of Incorporation
FAQ
Who has been appointed as the new Chief Financial Officer of STAAR Surgical Company?
Patrick Williams has been appointed as the new Chief Financial Officer of STAAR Surgical Company.
When is Patrick Williams' appointment as CFO effective?
Patrick Williams' appointment as CFO is effective March 11, 2024.
What was Patrick Williams' previous role at STAAR Surgical Company?
Patrick Williams previously served as Interim CFO.
What is the state of incorporation for STAAR Surgical Company?
STAAR Surgical Company is incorporated in Delaware.
What are the main items reported in this 8-K filing?
This 8-K filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD Disclosure, and Financial Statements and Exhibits.
Filing Stats: 1,087 words · 4 min read · ~4 pages · Grade level 10.6 · Accepted 2024-03-12 07:05:49
Filing Documents
- staa-20240310.htm (8-K) — 47KB
- staa-ex99_1.htm (EX-99.1) — 14KB
- img177331332_0.jpg (GRAPHIC) — 11KB
- 0000950170-24-029647.txt ( ) — 196KB
- staa-20240310.xsd (EX-101.SCH) — 29KB
- staa-20240310_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On March 12, 2024, the Company issued a press release regarding the appointment of Messrs. Butcher and Jiang to the Board. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference. The information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report and Exhibit 99.1 shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release of the Company dated March 12, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STAAR Surgical Company March 12, 2024 By: /s/ Tom Frinzi Thomas G. Frinzi President and Chief Executive Officer